Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 33 publications
Utilization of Steroid Sparing Agents for Immune-Related Adverse Events (irAEs): Management Strategies and Considerations.
Journal: Current oncology reports
Published: October 28, 2025
Corrigendum to "Precision immunomodulation: Understanding and harnessing cytokine pathways to treat and prevent immune-related adverse events (irAEs)" [Best Pract Res Clin Haematol 38 2 2025].
Journal: Best practice & research. Clinical haematology
Published: September 07, 2025
Predictors of Long-Term Survival in Patients With Immune Checkpoint Inhibitor-Associated Myocarditis.
Journal: Journal of the American Heart Association
Published: July 04, 2025
Precision immunomodulation: Understanding and harnessing cytokine pathways to treat and prevent immune-related adverse events (irAEs).
Journal: Best practice & research. Clinical haematology
Published: February 13, 2025
Impact of steroid-sparing immunosuppressive agents on tumor outcome in the context of cancer immunotherapy with highlight on melanoma: a systematic literature review and meta-analysis.
Journal: Frontiers in immunology
Published: September 20, 2024
Effects of immune-related adverse events (irAEs) and their treatment on antitumor immune responses.
Journal: Immunological reviews
Published: May 17, 2023
STK11 Inactivation Predicts Rapid Recurrence in Inoperable Early-Stage Non-Small-Cell Lung Cancer.
Journal: JCO precision oncology
Published: January 05, 2023
Immunotherapy partners after progression: Right place, right time?
Journal: Cancer
Published: November 24, 2022
Severe COVID-19 induces autoantibodies against angiotensin II that correlate with blood pressure dysregulation and disease severity.
Journal: Science advances
Published: October 07, 2022
Brief Report: Discordance Between Liquid and Tissue Biopsy-Based Next-Generation Sequencing in Lung Adenocarcinoma at Disease Progression.
Journal: Clinical lung cancer
Published: August 19, 2022
Association Between Rheumatic Autoantibodies and Immune-Related Adverse Events.
Journal: The oncologist
Published: July 03, 2022
Last Updated: 09/26/2026